CMPS — COMPASS Pathways Share News
0.000.00%
Last trade - 00:00Compass Pathways PLC expected to post a loss of 47 cents a share - Earnings Preview
Brief: Compass Pathways Establishes Strategic Collaboration With Healthport
Brief: Compass Pathways Announces Dosing Complete For All Participants In Part A Of Phase 3 Comp005 Trial Of Comp360 Psilocybin
U.S. STOCKS ON THE MOVE-Dow, Nike, Coty
U.S. STOCKS ON THE MOVE-Caterpillar, Netflix, Bank of America
Jefferies says J&J's depression drug sales bode well for psychedelics
Brief: Compass Pathways Announces Completion Of Recruitment For The Phase 3 COMP005 Trial Of COMP360 Psilocybin For Treatment-Resistant Depression
Compass Pathways PLC reports results for the quarter ended December 31 - Earnings Summary
Brief: COMPASS Pathways Q4 EPS USD -0.63
Compass Pathways PLC expected to post a loss of 62 cents a share - Earnings Preview
Brief: Compass Pathways To Announce Q4 And FY Results On Feb 27, 2025
Brief: Compass Pathways Announces Pricing Of Underwritten Offering
U.S. STOCKS ON THE MOVE-FuelCell Energy, consumer goods stocks, Rocket Companies
Psychedelic drug developers rise after RFK Jr picked for top US health agency role
U.S. STOCKS ON THE MOVE-OneStream, FuelCell Energy, Alibaba
Psychedelic drug developers rise as RFK Jr picked for top US health agency role
Psychedelic drug developer Atai rises as RFK Jr picked for top US health agency role
Compass Pathways PLC reports results for the quarter ended in September 30 - Earnings Summary
Strategic Reorganization To Focus All Efforts On Comp360 Program Resulting In Reduction Of Workforce Of About 30%